The Asia Pacific Insulin Syringes Market would witness market growth of 6.1% CAGR during the forecast period (2021-2027).
Insulin syringes are widely used among diabetic patients for easier diabetes care, with around 40% of patients injecting insulin using these syringes. Insulin syringes are single-use disposable devices. This ensures that the needles are sterile, reducing the danger of infection from previously used needles. To minimize lipohypertrophy, or an abnormal fat accumulation under the skin, it's also necessary to rotate injection sites. With daily insulin shots, it's a frequent problem. Insulin is injected subcutaneously — that is, just under the skin — to avoid the needle puncturing muscle, which might alter the blood sugar levels.
As the prevalence of diabetes rises, so will the need for insulin, which will have a favourable impact on market growth. Patients are increasingly using portable tools like insulin syringes for more convenient diabetes care, with roughly 40.0 percent of diabetics injecting insulin with syringes.
In China, unhealthy diets and a lack of physical activity are contributing to rising rates of overweight and obesity, both of which are risk factors for Type 2 diabetes. In China, more than a third of adults are overweight, with 7% of persons being obese. Youngsters in China are also at danger of acquiring diabetes as a result of unhealthy lifestyles: more than 4 in 5 teenagers aged 11 to 17 do not receive adequate physical activity, and obesity in children are fast rising. As a result, increased diabetes cases will propel the Insulin Syringes Market forward.
The China market dominated the Asia Pacific Insulin Syringes Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $182 million by 2027. The Japan market is anticipated to grow a CAGR of 5.6% during (2021 - 2027). Additionally, The India market would showcase a CAGR of 6.8% during (2021 - 2027).
Based on Disease, the market is segmented into Type 2 Diabetes and Type 1 Diabetes. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1CC Syringe (1ml) and Others. Based on End User, the market is segmented into Hospitals & Clinics, Homecare Settings, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Insulin Syringes Market is Projected to reach USD 2.1 Billion by 2027, at a CAGR of 4.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hindustan Syringes & Medical Devices Ltd., Novo Nordisk A/S, Biocon Limited, Eli Lilly and Company, Abbott Laboratories, Becton, Dickinson and Company, Cardinal Health, Inc., Medline Industries, Inc., Terumo Corporation, and Nipro Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Disease
- Type 2 Diabetes and
- Type 1 Diabetes
By Syringe Size
- 3/10 CC Syringe (0.3ml)
- 1/2 CC Syringe (0.5ml)
- 1CC Syringe (1ml) and
- Others
By End User
- Hospitals & Clinics
- Homecare Settings, and
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Hindustan Syringes & Medical Devices Ltd.
- Novo Nordisk A/S
- Biocon Limited
- Eli Lilly and Company
- Abbott Laboratories
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Medline Industries, Inc.
- Terumo Corporation
- Nipro Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Insulin Syringes Market, by Disease
1.4.2 Asia Pacific Insulin Syringes Market, by Syringe Size
1.4.3 Asia Pacific Insulin Syringes Market, by End User
1.4.4 Asia Pacific Insulin Syringes Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Insulin Syringes Market by Disease
3.1 Asia Pacific Type 2 Diabetes Market by Country
3.2 Asia Pacific Type 1 Diabetes Market by Country
Chapter 4. Asia Pacific Insulin Syringes Market by Syringe Size
4.1 Asia Pacific 3/10 CC Syringe (0.3ml) Market by Country
4.2 Asia Pacific 1/2 CC Syringe (0.5ml) Market by Country
4.3 Asia Pacific 1CC Syringe (1ml) Market by Country
4.4 Asia Pacific Other Syringe Size Market by Country
Chapter 5. Asia Pacific Insulin Syringes Market by End User
5.1 Asia Pacific Hospitals & Clinics Market by Country
5.2 Asia Pacific Homecare Settings Market by Country
5.3 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Insulin Syringes Market by Country
6.1 China Insulin Syringes Market
6.1.1 China Insulin Syringes Market by Disease
6.1.2 China Insulin Syringes Market by Syringe Size
6.1.3 China Insulin Syringes Market by End User
6.2 Japan Insulin Syringes Market
6.2.1 Japan Insulin Syringes Market by Disease
6.2.2 Japan Insulin Syringes Market by Syringe Size
6.2.3 Japan Insulin Syringes Market by End User
6.3 India Insulin Syringes Market
6.3.1 India Insulin Syringes Market by Disease
6.3.2 India Insulin Syringes Market by Syringe Size
6.3.3 India Insulin Syringes Market by End User
6.4 South Korea Insulin Syringes Market
6.4.1 South Korea Insulin Syringes Market by Disease
6.4.2 South Korea Insulin Syringes Market by Syringe Size
6.4.3 South Korea Insulin Syringes Market by End User
6.5 Singapore Insulin Syringes Market
6.5.1 Singapore Insulin Syringes Market by Disease
6.5.2 Singapore Insulin Syringes Market by Syringe Size
6.5.3 Singapore Insulin Syringes Market by End User
6.6 Malaysia Insulin Syringes Market
6.6.1 Malaysia Insulin Syringes Market by Disease
6.6.2 Malaysia Insulin Syringes Market by Syringe Size
6.6.3 Malaysia Insulin Syringes Market by End User
6.7 Rest of Asia Pacific Insulin Syringes Market
6.7.1 Rest of Asia Pacific Insulin Syringes Market by Disease
6.7.2 Rest of Asia Pacific Insulin Syringes Market by Syringe Size
6.7.3 Rest of Asia Pacific Insulin Syringes Market by End User
Chapter 7. Company Profiles
7.1 Hindustan Syringes & Medical Devices Ltd.
7.1.1 Company Overview
7.2 Novo Nordisk A/S
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental & Regional Analysis
7.2.4 Research & Development Expenses
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisitions and Mergers:
7.3 Biocon Limited
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.4 Eli Lilly and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent Strategies and Developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Approvals and Trials:
7.5 Abbott Laboratories
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Becton, Dickinson and Company
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Approvals and Trials:
7.9 Terumo Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.10. Nipro Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
TABLE 1 Asia Pacific Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 3 Asia Pacific Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 4 Asia Pacific Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 5 Asia Pacific Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 6 Asia Pacific Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 7 Asia Pacific Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 8 Asia Pacific Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 9 Asia Pacific Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 10 Asia Pacific Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 11 Asia Pacific 3/10 CC Syringe (0.3ml) Market by Country, 2017 - 2020, USD Million
TABLE 12 Asia Pacific 3/10 CC Syringe (0.3ml) Market by Country, 2021 - 2027, USD Million
TABLE 13 Asia Pacific 1/2 CC Syringe (0.5ml) Market by Country, 2017 - 2020, USD Million
TABLE 14 Asia Pacific 1/2 CC Syringe (0.5ml) Market by Country, 2021 - 2027, USD Million
TABLE 15 Asia Pacific 1CC Syringe (1ml) Market by Country, 2017 - 2020, USD Million
TABLE 16 Asia Pacific 1CC Syringe (1ml) Market by Country, 2021 - 2027, USD Million
TABLE 17 Asia Pacific Other Syringe Size Market by Country, 2017 - 2020, USD Million
TABLE 18 Asia Pacific Other Syringe Size Market by Country, 2021 - 2027, USD Million
TABLE 19 Asia Pacific Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 20 Asia Pacific Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 21 Asia Pacific Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 22 Asia Pacific Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 23 Asia Pacific Homecare Settings Market by Country, 2017 - 2020, USD Million
TABLE 24 Asia Pacific Homecare Settings Market by Country, 2021 - 2027, USD Million
TABLE 25 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
TABLE 26 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
TABLE 27 Asia Pacific Insulin Syringes Market by Country, 2017 - 2020, USD Million
TABLE 28 Asia Pacific Insulin Syringes Market by Country, 2021 - 2027, USD Million
TABLE 29 China Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 30 China Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 31 China Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 32 China Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 33 China Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 34 China Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 35 China Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 36 China Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 37 Japan Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 38 Japan Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 39 Japan Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 40 Japan Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 41 Japan Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 42 Japan Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 43 Japan Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 44 Japan Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 45 India Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 46 India Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 47 India Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 48 India Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 49 India Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 50 India Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 51 India Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 52 India Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 53 South Korea Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 54 South Korea Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 55 South Korea Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 56 South Korea Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 57 South Korea Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 58 South Korea Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 59 South Korea Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 60 South Korea Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 61 Singapore Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 62 Singapore Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 63 Singapore Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 64 Singapore Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 65 Singapore Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 66 Singapore Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 67 Singapore Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 68 Singapore Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 69 Malaysia Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 70 Malaysia Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 71 Malaysia Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 72 Malaysia Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 73 Malaysia Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 74 Malaysia Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 75 Malaysia Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 76 Malaysia Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 77 Rest of Asia Pacific Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 78 Rest of Asia Pacific Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 79 Rest of Asia Pacific Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 80 Rest of Asia Pacific Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 81 Rest of Asia Pacific Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 82 Rest of Asia Pacific Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 83 Rest of Asia Pacific Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 84 Rest of Asia Pacific Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 85 Key Information – Hindustan Syringes & Medical Devices Ltd.
TABLE 86 Key information – Novo Nordisk A/S
TABLE 87 Key Information – Biocon Limited
TABLE 88 Key Information – Eli Lilly and Company
TABLE 89 Key Information – Abbott Laboratories
TABLE 90 Key information – Becton, Dickinson and Company
TABLE 91 key information – Cardinal Health, Inc.
TABLE 92 Key Information – Medline Industries, Inc.
TABLE 93 Key Information – Terumo Corporation
TABLE 94 Key Information – Nipro Corporation
List of Figures
FIG 1 Methodology for the research